Shares of UnitedHealth Group Inc. (UNH) fell sharply in trading on March 27, 2026, significantly underperforming broader market indices. The stock closed at $259.02, a decline of 3.37% for the session.
Market Underperformance
The healthcare giant’s drop outpaced losses across major benchmarks. The S&P 500 index fell 1.67% on the same day. The Dow Jones Industrial Average declined 1.73%, and the technology-focused Nasdaq Composite lost 2.15%.
UnitedHealth’s stock has decreased 6.49% over the past month. This decline contributed to the Medical sector’s overall loss of 7.36% during that period. The S&P 500 fell 6.15% over the same timeframe.
Upcoming Earnings in Focus
Investor attention is turning to the company’s next earnings report, scheduled for release. According to consensus estimates compiled by Zacks Investment Research, analysts expect UnitedHealth to report earnings per share of $6.62. This would represent an 8.06% decrease from the same quarter a year prior.
Revenue for the quarter is projected to be $110.08 billion, indicating a slight 0.46% year-over-year increase. For the full fiscal year, the consensus estimate forecasts earnings of $17.7 per share and revenue of $440.36 billion.
Valuation and Analyst Perspective
Based on current estimates, UnitedHealth Group trades at a Forward Price-to-Earnings (P/E) ratio of 15.15. This aligns with the average Forward P/E of its industry peer group. The company’s PEG ratio, which factors in expected earnings growth, is 1.23.
The Medical – HMOs industry, of which UnitedHealth is a part, currently holds a Zacks Industry Rank of 230. This ranking places it in the bottom 7% of more than 250 industries covered. The Zacks Rank for UnitedHealth stock is currently #3 (Hold).
There has been no change to the consensus EPS estimate over the past month. Revisions to analyst estimates often reflect shifting views on near-term business trends and can influence stock performance.
Sector and Industry Context
The broader Medical sector has faced headwinds recently. The industry’s average PEG ratio was 0.94 at the previous market close. Research indicates that industries ranked in the top 50% by Zacks tend to outperform the bottom half by a significant margin.
Market data and analyst research are key tools for investors monitoring stock movements. Primary sources for this information include official SEC filings and financial data providers.
Investors will continue to assess UnitedHealth’s performance against its upcoming financial results and the overall trajectory of the healthcare sector.
This article was produced with AI assistance and reviewed by our editorial team for accuracy and quality.
